VANCE WEALTH, INC. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 97 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANCE WEALTH, INC. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$73,427
-25.5%
39,2660.0%0.03%
-24.4%
Q2 2023$98,558
+43.4%
39,2660.0%0.04%
+21.6%
Q1 2023$68,716
+21.6%
39,266
+195.3%
0.04%
+5.7%
Q4 2022$56,521
+253.3%
13,2990.0%0.04%
+191.7%
Q3 2022$16,000
+23.1%
13,2990.0%0.01%
+20.0%
Q2 2022$13,000
-60.6%
13,2990.0%0.01%
-76.2%
Q1 2022$33,0000.0%13,299
+8.1%
0.04%
+31.2%
Q4 2021$33,00012,2990.03%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders